ZytoMax

EUIPO EUIPO 2021 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ZytoMax was filed as Word mark on 11/29/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/13/2022. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 018610296
Application date November 29, 2021
Publication date April 5, 2022
Entry date July 13, 2022
Expiration date November 29, 2031

Trademark owner

Fischkai 1
27572 Bremerhaven
DE

Trademark representatives

goods and services

1 Chemicals for use in industry and science; Chemicals, Biochemicals, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, Biotechnology, Laboratory medicine; Chemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins; Nucleic acids (including DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, DNA probes being biochemical substances, RNA probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
5 Pharmaceuticals and medical preparations; Medical preparations for diagnostics; Medical preparations for in-vitro diagnostics; Pharmaceuticals, Pharmaceutical preparations, medical products, Medical preparations, Chemical products, chemical preparations, Biochemical products, Biochemical preparations, For medical use, for use in the following fields: pathology, Genetics, Human genetics, molecular pathologies, Molecular biology, Microbiology, biotechnology, laboratory medicine; Pharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including DNA, RNA and proteins; Nucleic acids (including DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, DNA probes being biochemical substances, RNA probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
9 Scientific research and laboratory apparatus, educational apparatus and simulators; Analysis apparatus for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, Analysis apparatus for research laboratories for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins
10 Medical apparatus and instruments; Medical instruments; Medical analytical apparatus for medical purposes; Automatic analyzers for medical diagnosis; Physical analyzers for medical use; Genetic testing apparatus for medical purposes
35 Business management consultancy and advisory services; Operation of businesses [for others]; Running of a holding company, namely business management, Business administration, office functions; Holding company services, namely Marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; Business management and organization consultancy; Advisory services for business management; Business administration; Office functions; Planning and monitoring of business developments with regard to organisational matters
42 Science and technology services; Medical laboratory services; Medical research laboratory services; Development of pharmaceutical preparations and medicines; Clinical research; Research relating to biotechnology; Scientific consultancy services; Biological analysis, Biochemical analysis, Chemical analysis, Scientific analysis; Scientific research in the field of genetics and genetic engineering
44 Medical services; Diagnostic services; In-vitro diagnostic services; Medical services, in relation to the following fields: pathology, genetic science, Human genetics, molecular pathologies, Molecular biology, Microbiology, Biotechnology and laboratory medicine; Medical services by means of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; Medical counseling; Pharmaceutical services; Pharmaceutical advice; Medical and health services relating to DNA, genetics and genetic testing; Pathology services; Genetic testing for medical purposes

ID: 11018610296